Is Chronic AhR Activation by Rapidly Metabolized Ligands Safe for the Treatment of Immune-Mediated Diseases?

Current Opinion in Toxicology - Netherlands
doi 10.1016/j.cotox.2017.01.007
Full Text
Abstract

Available in full text

Categories
Toxicology
Date
Authors
Publisher

Elsevier BV